AST

Asterias Biotherapeutics, Inc. (AST)

Asterias Biotherapeutics Common Series A

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:AST

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2019/03/21	06 : 07	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/20	19 : 02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/20	19 : 02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/20	19 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/15	03 : 55	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/15	03 : 55	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/15	03 : 53	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/15	03 : 52	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/15	03 : 50	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/15	03 : 49	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/15	03 : 48	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/13	06 : 00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/13	05 : 52	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/12	19 : 06	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/09	06 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/09	05 : 18	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/06	06 : 35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/06	06 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/06	06 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/02	06 : 35	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/02	06 : 34	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/03/01	07 : 24	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/02/05	07 : 26	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/01/25	06 : 01	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/01/24	21 : 00	GlobeNewswire Inc.	Asterias Provides Top Line 12 Month Data Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/01/05	07 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/01/05	07 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
2019/01/04	22 : 00	GlobeNewswire Inc.	BioTime Announces Management Changes Concurrent With Participation at 2019 J.P. Morgan Healthcare Conference and 2019 Biotech...	AMEX:AST	Asterias Biotherapeutics Common Series A
2018/12/06	20 : 22	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
2018/12/06	20 : 17	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A